Boston Institute of Biotechnology
↗Southborough, USA
Boston Institute of Biotechnology (BIB) is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in large-molecule biologics. Founded in 2014, the company provides a full spectrum of services including microbial fermentation, mammalian cell culture, gene therapy (AAV, pDNA), and antibody-drug conjugates (ADC). BIB is recognized for its disruptive 'PanFlex-Engineering' system, which allows for the construction of GMP facilities at half the traditional time and cost.
In partnership with its sister company, BiBo Pharma, BIB operates a global network of R&D centers and GMP factories. The company is a pioneer in ultra-large-scale manufacturing, having introduced the world's first 30,000L stainless steel bioreactor. Their strategic mission is to revolutionize the cost of biologics production, aiming to reduce the cost of monoclonal antibodies from hundreds of dollars per gram to as low as $10 per gram to increase global accessibility.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M (estimated)
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Late Stage / Private Equity
Total Raised:Unknown (Significant recent investment for 350,000L capacity expansion)
Investors:BiBo Pharma (Sister Company/Partner)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (CDMO Services)
Modalities:mAb, ADC, Cell therapy, Gene therapy, Recombinant Proteins, Microbial Fermentation
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:BiBo Pharma (Sister Company)
Key Partnerships:BiBo Pharma (Global manufacturing partner), Cytiva (Bioreactor scaling tools)
COMPETITION
Position:Emerging
Competitors:WuXi Biologics, Lonza, Catalent, Samsung Biologics, AGC Biologics, Fujifilm Diosynth Biotechnologies
LEADERSHIP
Key Executives:
Peng Jiao, Ph.D. - Founder, President & CEO
W. Roy Lin, Ph.D. - Chief Technology Officer
Qi Xu - Vice President
Scientific Founders:Peng Jiao, Ph.D.
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Boston Institute of Biotechnology. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.